Sangamo BioSciences | Pasivo Circulante





Pasivo Circulante Cambio Fecha
Alaunos Therapeutics USD 921K 153K 2025-09
Alnylam Pharmaceuticals USD 1.47B 89.13M 2025-12
Alterity Therapeutics Limited AUD 4.38M 849.82K 2023-06
Amgen USD 25.49B 3.7B 2025-12
Bayer EUR 28.96B 825M 2025-09
BioCryst Pharmaceuticals USD 190.24M 13.08M 2025-09
Biogen USD 3.35B 59.4M 2025-12
BioMarin Pharmaceutical USD 759.03M 39.41M 2025-12
Cipla INR 62.97B 8.13B 2025-09
Clal Biotechnology ILS 6.66M 3.75M 2023-12
Compugen USD 20.28M 300K 2025-09
CSL USD 4.61B 207M 2025-12
Gilead Sciences USD 11.81B 485M 2025-12
GlaxoSmithKline GBP 21.39B 57M 2025-12
Grifols EUR 2.53B 182.67M 2025-09
Ionis Pharmaceuticals USD 783M 120.46M 2025-12
J&J USD 54.13B 3.26B 2025-12
Karyopharm Therapeutics USD 87.16M 12.06M 2025-09
Merck USD 28.63B 2.59B 2025-09
Novartis USD 32B 286M 2025-09
Omeros USD 85.5M 2.28M 2025-06
Pfizer USD 36.6B 1.13B 2025-09
Roche Holding CHF 28B 421M 2025-12
Sangamo BioSciences USD 47.66M 1.9M 2025-06
Sanofi EUR 28.35B 3.76B 2025-12
Sarepta Therapeutics USD 1.1B 173.86M 2025-12
Tectonic Therapeutic USD 9.37M 1.99M 2025-09
Ultragenyx Pharmaceutical USD 340.02M 46.78M 2025-09
Vertex Pharmaceuticals USD 3.86B 614.1M 2025-12


Sangamo BioSciences Pasivo Circulante - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Mar 2026.